ALEC Company Profile and Key Details

Q: Who are the executives of ALEC?

Mr. Calvin YuVice President of Fin.Dr. Tillman Ulf Gerngross Ph.D.Co-Founder & ChairmanMr. Peter Heutink Ph.D.Chief Scientific OfficerDr. Sara Kenkare-Mitra Ph.D.Pres and Head of R&DMs. Danielle Pasqualone J.D., Ph.D.Gen. CounselMs. Kristina Cutter M.P.H.Chief Regulatory, Pharmacovigilance, & Quality Assurance OfficerErica JeffersonVice President of Communications & Public AffairsDr. Gary Romano M.D., Ph.D.Chief Medical OfficerMichelle CorralVice President of Communications & Investor RelationsDr. Marc Grasso M.D.AdvisorMs. Clare Hunt M.B.A.Chief People OfficerDr. Arnon Rosenthal Ph.D.Founder

NASDAQ : ALEC

Alector

$2.54

0.175+7.42%

Open: 3:45 PM

60.69

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Alector, Inc. (ALEC) stock surged +7.42%, trading at $2.54 on NASDAQ, up from the previous close of $2.36. The stock opened at $2.35, fluctuating between $2.35 and $2.54 in the recent session.

Stock Snapshot

2.36

Prev. Close

281.45M

Market Cap

2.35

Day Low

-1.82

P/E Ratio

-1.39

EPS (TTM)

-2.21

Cash Flow per Share

2.35

Open

111.03M

Number of Shares

2.54

Day High

83.56%

Free Float in %

1.59

Book Value

213.27K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 30, 2026	2.29	2.44	2.15	2.37	713.18K
Apr 29, 2026	2.36	2.38	2.27	2.30	341.55K
Apr 28, 2026	2.35	2.42	2.35	2.39	297.07K
Apr 27, 2026	2.41	2.47	2.33	2.35	592.89K
Apr 23, 2026	2.52	2.52	2.38	2.43	303.38K
Apr 22, 2026	2.48	2.70	2.37	2.45	1.42M
Apr 21, 2026	2.70	2.73	2.45	2.46	298.04K
Apr 20, 2026	2.56	2.74	2.56	2.71	324.76K
Apr 17, 2026	2.62	2.62	2.49	2.57	342.94K
Apr 16, 2026	2.52	2.67	2.47	2.55	560.13K
Apr 14, 2026	2.35	2.44	2.34	2.41	394K
Apr 13, 2026	2.44	2.44	2.28	2.33	362.21K
Apr 10, 2026	2.40	2.53	2.40	2.45	572.97K
Apr 09, 2026	2.38	2.42	2.34	2.40	278.54K
Apr 08, 2026	2.58	2.60	2.38	2.42	339.82K
Apr 07, 2026	2.34	2.49	2.30	2.47	562.11K
Apr 06, 2026	2.41	2.49	2.33	2.35	582.33K
Apr 02, 2026	2.45	2.52	2.13	2.41	1.32M
Apr 01, 2026	2.18	2.64	2.16	2.53	3.3M
Mar 31, 2026	2.03	2.19	2.03	2.15	351.55K

Contact Details

South San Francisco, CA 94080

United States

https://www.alector.com 415 231 5660

About Company

Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease; and AL003, which is in Phase I clinical trial for the treatment of Alzheimer's disease. In addition, its products in development stage include AL044 that targets MS4A4A, a risk gene for Alzheimer's disease. Alector, Inc. has a collaboration agreement with Adimab, LLC for the research and development of antibodies; and a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of monoclonal antibodies, such as AL001 and AL101 to treat neurodegenerative diseases. The company was founded in 2013 and is headquartered in South San Francisco, California.

Stock Peers

ARGX

5.7+0.73%

argenx SE$781.72 REGN

20.7+3.02%

Regeneron Pharmaceuticals, Inc.$707.06 UTHR

0.28+0.05%

United Therapeutics Corporation$571.35 MDGL

-1.19-0.23%

Madrigal Pharmaceuticals, Inc.$517.39 VRTX

4.14+0.98%

Vertex Pharmaceuticals Incorporated$427.38 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

-4.36-1.35%

Praxis Precision Medicines, Inc.$318.83 ALNY

8.3+2.76%

Alnylam Pharmaceuticals, Inc.$309.49 KRYS

2.31+0.89%

Krystal Biotech, Inc.$262.26 LGND

4.59+2.04%

Ligand Pharmaceuticals Incorporated$229.45

Frequently Asked Questions

What is the current Alector, Inc. (ALEC) stock price?

Alector, Inc. (NASDAQ: ALEC) stock price is $2.54 in the last trading session. During the trading session, ALEC stock reached the peak price of $2.54 while $2.35 was the lowest point it dropped to. The percentage change in ALEC stock occurred in the recent session was 7.42% while the dollar amount for the price change in ALEC stock was $0.18.

ALEC's industry and sector of operation?

The NASDAQ listed ALEC is part of Biotechnology industry that operates in the broader Healthcare sector. Alector, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ALEC?

Mr. Calvin Yu
Vice President of Fin.
Dr. Tillman Ulf Gerngross Ph.D.
Co-Founder & Chairman
Mr. Peter Heutink Ph.D.
Chief Scientific Officer
Dr. Sara Kenkare-Mitra Ph.D.
Pres and Head of R&D
Ms. Danielle Pasqualone J.D., Ph.D.
Gen. Counsel
Ms. Kristina Cutter M.P.H.
Chief Regulatory, Pharmacovigilance, & Quality Assurance Officer
Erica Jefferson
Vice President of Communications & Public Affairs
Dr. Gary Romano M.D., Ph.D.
Chief Medical Officer
Michelle Corral
Vice President of Communications & Investor Relations
Dr. Marc Grasso M.D.
Advisor
Ms. Clare Hunt M.B.A.
Chief People Officer
Dr. Arnon Rosenthal Ph.D.
Founder

How ALEC did perform over past 52-week?

ALEC's closing price is 143.58% higher than its 52-week low of $0.97 where as its distance from 52-week high of $3.40 is -30.29%.

How many employees does ALEC have?

Number of ALEC employees currently stands at 175.

Link for ALEC official website?

Official Website of ALEC is: https://www.alector.com

How do I contact ALEC?

ALEC could be contacted at phone 415 231 5660 and can also be accessed through its website. ALEC operates from 131 Oyster Point Boulevard, South San Francisco, CA 94080, United States.

How many shares of ALEC are traded daily?

ALEC stock volume for the day was 213.27K shares. The average number of ALEC shares traded daily for last 3 months was 762.36K.

What is the market cap of ALEC currently?

The market value of ALEC currently stands at $281.45M with its latest stock price at $2.54 and 111.03M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	175
Beta	0.58
Sales or Revenue	$97.06M
5Y Sales Change%	1.863%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	175
Beta	0.58
Sales or Revenue	$97.06M
5Y Sales Change%	1.863%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

ALEC Company Profile and Key Details

Alector

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Earnings & Analyst Outlook

Shareholding & Insider Activity

Dividend & Fair Value

Company Overview

Price Forecast & Outlook

Key Takeaways

Valuation Metrics